Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight
14. November 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight The demand for organoids is being driven mainly by an...
NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight
13. November 2024 12:30 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment |...
Non-Cystic Fibrosis Bronchiectasis Pipeline Insight: Over 15 Companies are Progressing Through to Improve the Treatment Landscape | DelveInsight
13. November 2024 10:30 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Non-Cystic Fibrosis Bronchiectasis Pipeline Insight: Over 15 Companies are Progressing Through to Improve the Treatment Landscape | DelveInsight The...
Tetanus Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight
06. November 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Tetanus Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight Tetanus is a serious bacterial infection caused by Clostridium...
Global Alopecia Treatment Market is Anticipated to Surpass ~USD 4 Billion by 2030 | DelveInsight
05. November 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Global Alopecia Treatment Market is Anticipated to Surpass ~USD 4 Billion by 2030 | DelveInsight The growing demand for alopecia treatments is...
Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight
04. November 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight The rising prevalence of urticaria...
Global Plasma Protein Therapeutics Market to Touch ~USD 40 Billion Mark by 2030 | DelveInsight
31. Oktober 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Global Plasma Protein Therapeutics Market to Touch ~USD 40 Billion Mark by 2030 | DelveInsight The plasma protein therapeutics market is...
Advancements in Sensorineural Hearing Loss Clinical Trial Pipeline as 20+ Companies Pave the Way for Future Solutions | DelveInsight
30. Oktober 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Advancements in Sensorineural Hearing Loss Clinical Trial Pipeline as 20+ Companies Pave the Way for Future Solutions | DelveInsight Sensorineural...
Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight
29. Oktober 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight The exosome market is fueled by several significant factors,...
Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight
28. Oktober 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight ...